|
YAF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.17130002866384E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.23680000474869E-08 |
| Normal-vs-Stage2 |
2.837400E-03 |
| Normal-vs-Stage3 |
2.759400E-03 |
| Normal-vs-Stage4 |
9.70789999999999E-05 |
| Stage1-vs-Stage2 |
2.308800E-01 |
| Stage1-vs-Stage3 |
9.705000E-01 |
| Stage1-vs-Stage4 |
6.046600E-01 |
| Stage2-vs-Stage3 |
2.738400E-01 |
| Stage2-vs-Stage4 |
1.690640E-01 |
| Stage3-vs-Stage4 |
7.211200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.0043999510454E-09 |
| Normal-vs-AfricanAmerican |
1.445720E-02 |
| Normal-vs-Asian |
3.001600E-02 |
| Caucasian-vs-AfricanAmerican |
3.039900E-02 |
| Caucasian-vs-Asian |
6.999000E-01 |
| AfricanAmerican-vs-Asian |
5.548000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.23689999967469E-07 |
| Normal-vs-Female |
6.06569999783702E-08 |
| Male-vs-Female |
9.981400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.871630E-01 |
| Normal-vs-Age(41-60Yrs) |
1.85520000028916E-07 |
| Normal-vs-Age(61-80Yrs) |
1.24580000004926E-06 |
| Normal-vs-Age(81-100Yrs) |
8.23910000000705E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.985850E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.941700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.866500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.802400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.251400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.738000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.215900E-03 |
| Normal-vs-Grade 2 |
3.00799999997103E-06 |
| Normal-vs-Grade 3 |
1.29759999967227E-07 |
| Normal-vs-Grade 4 |
3.798900E-03 |
| Grade 1-vs-Grade 2 |
5.714200E-01 |
| Grade 1-vs-Grade 3 |
8.901200E-01 |
| Grade 1-vs-Grade 4 |
4.844800E-01 |
| Grade 2-vs-Grade 3 |
2.116800E-01 |
| Grade 2-vs-Grade 4 |
5.005800E-02 |
| Grade 3-vs-Grade 4 |
2.269400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.93109999499808E-08 |
| Normal-vs-ccB subtype |
3.71479999999869E-05 |
| ccA subtype-vs-ccB subtype |
6.966800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.03069999979333E-07 |
| Normal-vs-N1 |
2.621400E-03 |
| N0-vs-N1 |
5.051000E-01 |
|
|
